These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2381055)

  • 21. Radical radiotherapy of localised prostate cancer: the relationship between radiation dose and survival.
    Magrini SM; Cellai E; Pertici M; Rossi F; Ponticelli P; Odantini R; Cappellini M; Biti GP
    Cancer Radiother; 1998; 2(4):351-8. PubMed ID: 9755748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [External radiotherapy with curative intent for adenocarcinoma clinically localized to the prostate (T1 to T3N0M0): intermediate results with a minimum follow-up of 4 years].
    Rohner S; Bieri S; Graber P
    Ann Urol (Paris); 1994; 28(4):221-8. PubMed ID: 7979212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic significance of clinical stage including extent of disease (EOD) in prostate cancer].
    Fujinami K; Kondo I; Miura T; Harada M; Uemura H; Hosaka M; Kawasaki C
    Hinyokika Kiyo; 1998 Apr; 44(4):259-63. PubMed ID: 9617622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy for prostatic cancer.
    Flocks RH
    Urol Clin North Am; 1975 Feb; 2(1):181-3. PubMed ID: 1128747
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
    Fang LC; Dattoli M; Taira A; True L; Sorace R; Wallner K
    Urology; 2008 Jan; 71(1):146-50. PubMed ID: 18242384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjuvant radiotherapy following radical prostatectomy--results, acute and late toxicity].
    Wiegel T; Bressel M; Baumann M; Schwarz R; Hübener KH
    Strahlenther Onkol; 1993 Mar; 169(3):152-8. PubMed ID: 8465249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases.
    Wiegel T; Tepel J; Schmidt R; Klosterhalfen H; Arps H; Berger P; Franke HD
    Strahlenther Onkol; 1996 Nov; 172(11):596-603. PubMed ID: 8946031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer.
    Cox JD; Kline RW
    Semin Urol; 1983 Nov; 1(4):237-42. PubMed ID: 6681484
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
    Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of split-course radiotherapy on survival and local control in advanced localized prostatic carcinoma.
    Kajanti M; Holsti LR; Holsti P; Möykkynen K
    Int J Radiat Oncol Biol Phys; 1993 May; 26(2):211-6. PubMed ID: 8491679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fast neutron irradiation of locally advanced prostate cancer.
    Griffin TW; Krall JM; Russell KJ; Peters LJ; Thomas FJ; Hendrickson FR; Laramore GE
    Semin Oncol; 1988 Aug; 15(4):359-65. PubMed ID: 3406756
    [No Abstract]   [Full Text] [Related]  

  • 34. Four-week arc radiotherapy for B2-C prostate cancer: the need for prospective evaluation of short fractionation schemes.
    Graham PH; Morris WJ; Pickles TP
    Australas Radiol; 1997 Aug; 41(3):266-9. PubMed ID: 9293678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radiotherapy of prostatic carcinoma].
    Akimoto S; Fuse H; Shimazaki J; Morita S; Tsunemoto H
    Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1584-90. PubMed ID: 3444185
    [No Abstract]   [Full Text] [Related]  

  • 36. External-beam radiation for carcinoma of the prostate.
    Davies AH; Davis HL; Ramarakha P; Durrant KD; Fellows GJ
    Eur Urol; 1990; 18(2):117-9. PubMed ID: 2226579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional external beam radiation therapy for prostatic cancer: where do we go from here?
    Zelefsky MJ; Leibel SA; Fuks Z
    Int J Radiat Oncol Biol Phys; 1993 May; 26(2):365-7; discussion 373. PubMed ID: 8491696
    [No Abstract]   [Full Text] [Related]  

  • 38. [Irradiation of prostatic cancer (75 cases)].
    Grasset D; Pourquier H; Navratil H; Subrini L; Guiter J; Averous M; Bordat JP
    J Urol Nephrol (Paris); 1977; 83 Suppl 2():528-32. PubMed ID: 617731
    [No Abstract]   [Full Text] [Related]  

  • 39. Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?
    Zincke H
    Cancer; 1992 Dec; 70(11):2742-3. PubMed ID: 1423207
    [No Abstract]   [Full Text] [Related]  

  • 40. Definitive radiotherapy of prostatic cancer: a progress report.
    Birkhead BM
    J Ky Med Assoc; 1978 Mar; 76(3):118-20. PubMed ID: 632655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.